Google DeepMind launched AlphaGenome, an AI tool that identifies genetic mutations driving disease.
The system predicts how DNA changes disrupt gene regulation across different cells and tissues.
AlphaGenome can analyse up to one million DNA letters in a single sequence.
Researchers trained it on large human and mouse genetics databases.
Scientists say it could accelerate discovery of cancer drivers and inherited diseases.
The tool may also support new gene therapies by designing precise DNA sequences.
Andrew Rogers
Andrew Rogers is a freelance journalist based in the USA, with over 10 years of experience covering Politics, World Affairs, Business, Health, Technology, Finance, Lifestyle, and Culture. He earned his degree in Journalism from the University of Florida. Throughout his career, he has contributed to outlets such as The New York Times, CNN, and Reuters. Known for his clear reporting and in-depth analysis, Andrew delivers accurate and timely news that keeps readers informed on both national and international developments.
Add A Comment